Table 2.
Descriptive statistics of the patients’ dataset, with statistical comparison between Amb a 11-positive and -negative subsets.
| Parameters † | Patients Group (n = 150) |
Amb a 11 Positive (n = 103) | Amb a 11 Negative (n = 47) |
p Value |
|---|---|---|---|---|
| Age (years) | 35.91 ± 8.75 (18–61, 35) | 36.04 ± 8.93 (18–61, 35) | 35.62 ± 8.43 (20–61, 34) | >0.05 NS |
| Age groups | 18–39 years: 106 (70.67%) 40–54 years: 39 (26%) ≥55 years: 5 (3.33%) |
18–39 years: 73 (70.88%) 40–54 years: 27 (26.21%) ≥55 years: 3 (2.91%) |
18–39 years: 33 (70.21%) 40–54 years: 12 (25.53%) ≥55 years: 2 (4.26%) |
>0.05 NS |
| Sex | Women: 50 (33.33%) Men: 100 (66.67%) |
Women: 38 (36.89%) Men: 65 (63.11%) |
Women: 12 (25.53%) Men: 35 (74.47%) |
<0.05 S |
| Allergy history (years) | 5.06 ± 4.96 (1–32, 3) | 5.28 ± 4.84 (1–24, 3) | 4.56 ± 5.23 (1–32, 3) | >0.05 NS |
| Family history of allergic disease | Negative: 107 (71.33%) Positive: 43 (28.67%) |
Negative: 72 (69.9%) Positive: 31 (30.1%) |
Negative: 35 (74.47%) Positive: 12 (25.53%) |
>0.05 NS |
| Exposure factors | ||||
| Smoking | Non-smokers: 89 (59.33%) Smokers: 61 (40.67%) |
Non-smokers: 61 (59.22%) Smokers: 42 (40.78%) |
Non-smokers: 28 (59.57%) Smokers:19 (40.43%) |
>0.05 NS |
| Professional (organic solvents, dust, etc.) | Negative: 122 (81.33%) Positive: 28 (18.67%) |
Negative: 84 (81.55%) Positive: 19 (18.45%) |
Negative: 38 (80.85%) Positive: 9 (19.15%) |
>0.05 NS |
| Pets | Negative: 96 (64%) Positive: 54 (36%) |
Negative: 71 (68.93%) Positive: 32 (31.07%) |
Negative: 25 (53.19%) Positive: 22 (46.81%) |
<0.05 S |
| Clinical data | ||||
| Allergy pattern | Monosensitized: 45 (30%) Polysensitized: 105 (70%) |
Monosensitized: 38 (36.89%) Polysensitized: 65 (63.11%) |
Monosensitized: 7 (14.89%) Polysensitized: 40 (85.11%) |
<0.05 S |
| Additional positive skin prick test results | House dust mite: 54 (36%) Cereal/grass pollen: 48 (32%) Artemisia: 42 (28%) Fungi: 27 (18%) Tree pollen: 25 (16.67%) |
House dust mite: 35 (33.98%) Cereal/grass pollen: 26 (25.24%) Artemisia: 24 (23.3%) Fungi: 15 (14.56%) Tree pollen: 13 (12.62%) |
House dust mite: 19 (40.43%) Cereal/grass pollen: 22 (46.81%) Artemisia: 18 (38.30%) Fungi: 12 (25.53%) Tree pollen: 12 (25.53%) |
>0.05 NS <0.05 S <0.05 S <0.05 S <0.05 S |
| Allergy season (months) | 3.24 ± 1.86 (1–12, 3) | 3.06 ± 1.74 (1–12, 2) | 3.66 ± 2.06 (1–12, 3) | >0.05 NS |
| Symptoms score (on a 1–12 scale for rhinitis/asthma, 1–9 scale for conjunctivitis/urticaria) and frequency of disease |
Rhinitis: 7.27 ± 2.80 (1–12, 8) 149 patients (99.33%) Conjunctivitis: 4.58 ± 2.3 (1–9, 4) 136 patients (90.67%) Asthma: 3.47 ± 2.38 (1–11, 3) 90 patients (60%) Urticaria: 3.11 ± 1.87 (1–9, 3) 37 patients (24.67%) Edema: 13 patients (8.67%) |
Rhinitis: 7.30 ± 2.88 (1–12, 8) 103 patients (100%) Conjunctivitis: 4.6 ± 2.43 (1–9, 4) 95 patients (92.23%) Asthma: 3.84 ± 2.54 (1–11, 3) 63 patients (61.17%) Urticaria: 3.17 ± 2.04 (1–9, 3) 24 patients (23.3%) Edema: 8 patients (7.77%) |
Rhinitis: 7.20 ± 2.66 (1–12, 8) 46 patients (97.87%) Conjunctivitis: 4.54 ± 2.01 (1–9, 5) 41 patients (87.23%) Asthma: 2.59 ± 1.69 (1–6, 2) 27 patients (57.45%) Urticaria: 3 ± 1.58 (1–6, 3) 13 patients (27.66%) Edema: 5 patients (10.64%) |
>0.05 NS >0.05 NS >0.05 NS >0.05 NS <0.05 S >0.05 NS >0.05 NS >0.05 NS >0.05 NS |
| Quality of Life indicators | ||||
| Sleep disturbance | Absent: 48 (32%) Present: 102 (68%) |
Absent: 31 (30.1%) Present: 72 (69.9%) |
Absent: 17 (36.17%) Present: 30 (63.83%) |
>0.05 NS |
| Allergy-related hospitalization | Absent: 133 (88.67%) Present: 17 (21.33%) |
Absent: 88 (85.44%) Present: 15 (14.56%) |
Absent: 45 (95.74%) Present: 2 (4.26%) |
>0.05 NS |
| Activity impairment score (1–10 scale) | 6.88 ± 2.62 (1–10, 7.5) | 7.09 ± 2.60 (1–10, 8) | 6.43 ± 2.64 (1–10, 7) | >0.05 NS |
† Numerical variables presented as: mean ± standard deviation (minimum–maximum and median). Categorical variables presented as: frequency (cases) and percentage.